Hematologic Malignancies

Joint Session 03 - (INTERACTIVE) Everything They Can Do In Lymphoma- You Can Do Better With the Integration of Radiotherapy: New Data in Support of RT Across the Lymphomas Disease Spectrum

9/17/2019
4:45 PM - 6:00 PM
Location: Room W184

Session Type: Joint Association
1.25 AMA PRA Category 1 Credits™
1.25 CAMPEP Credits
1.50 MDCB Credits

-First session will provide new (2018) information of prospective studies that document the need to use RT in classical Hodgkin lymphoma (first section- Dr. Joachim Yahalom- MSKCC).
- Second session will dissect flawed recent studies that diminish the role of RT in Diffuse large B-cell Lymphoma (Dr. Bouthaina Dabaja- MDACC)
-Third session will detail recent ILROG collaborative studies on the role of RT in follicular lymphomas and provide modeling based on large national data bases documenting the cost-effectiveness of RT over systemic therapies or eatch and wait approach to indolent lymphomas 9Dr. Joanna Yang (UCSF)

Proposed Moderator- Dr. Joachim Yahalom- ILROG Chairman

Learning Objectives:

Presentations:

Joachim Yahalom, MD, FASTRO

Memorial Sloan Kettering Cancer Center

Disclosure:
Employment
Memorial Sloan Kettering Cancer Center

Leadership
ILROG: Chairman: Chairman

Presentation(s):

Send Email for Joachim Yahalom


Assets

Joint Session 03 - (INTERACTIVE) Everything They Can Do In Lymphoma- You Can Do Better With the Integration of Radiotherapy: New Data in Support of RT Across the Lymphomas Disease Spectrum



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Joint Session 03 - (INTERACTIVE) Everything They Can Do In Lymphoma- You Can Do Better With the Integration of Radiotherapy: New Data in Support of RT Across the Lymphomas Disease Spectrum